Novartis AGNVSNYSE
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR+10.8%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+10.8%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202522.47%
2024-17.20%
2023124.14%
2022-70.21%
2021202.54%
202013.46%
2019-42.65%
201865.85%
201716.31%
2016-61.89%